KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Asset Writedowns and Impairment (2022 - 2024)

Cvs Health's Asset Writedowns and Impairment history spans 3 years, with the latest figure at -$840.0 million for Q4 2024.

  • For the quarter ending Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to -$840.0 million, compared with a TTM value of -$233.0 million through Dec 2024, down 164.54%, and an annual FY2023 reading of $152.0 million, down 94.0% over the prior year.
  • Asset Writedowns and Impairment for Q4 2024 was -$840.0 million at Cvs Health, down from $607.0 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $2.5 billion in Q3 2022, with the low at -$840.0 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 3 years is $441.5 million, with a median of $195.0 million recorded in 2022.
  • Biggest YoY gain for Asset Writedowns and Impairment was 751.22% in 2023; the steepest drop was 751.22% in 2023.
  • Tracing CVS's Asset Writedowns and Impairment over 3 years: stood at $12.0 million in 2022, then soared by 2808.33% to $349.0 million in 2023, then plummeted by 340.69% to -$840.0 million in 2024.
  • Per Business Quant, the three most recent readings for CVS's Asset Writedowns and Impairment are -$840.0 million (Q4 2024), $607.0 million (Q3 2024), and $349.0 million (Q1 2023).